Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Cambridge Cognition Holdings stock price, quote, forecast and news

COG.L
GB00B8DV9647
A1T9LW

Price

0.43
Today +/-
+0
Today %
+0 %
P

Cambridge Cognition Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Cambridge Cognition Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Cambridge Cognition Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Cambridge Cognition Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Cambridge Cognition Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Cambridge Cognition Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Cambridge Cognition Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Cambridge Cognition Holdings’s growth potential.

Cambridge Cognition Holdings Revenue, EBIT and net profit per share

DateCambridge Cognition Holdings RevenueCambridge Cognition Holdings EBITCambridge Cognition Holdings Net Income
2026e18.16 M undefined3.89 M undefined3.12 M undefined
2025e16.21 M undefined1.72 M undefined1.86 M undefined
2024e14.42 M undefined736,450 undefined0 undefined
202313.52 M undefined-1.85 M undefined-3.51 M undefined
202212.61 M undefined-138,000 undefined-409,000 undefined
202110.09 M undefined264,000 undefined450,000 undefined
20206.74 M undefined-644,000 undefined-438,000 undefined
20195.04 M undefined-3.12 M undefined-2.9 M undefined
20186.13 M undefined-1.49 M undefined-1.44 M undefined
20176.73 M undefined-284,000 undefined-257,000 undefined
20166.88 M undefined116,000 undefined272,000 undefined
20155.04 M undefined-659,000 undefined-782,000 undefined
20145.8 M undefined-304,000 undefined-173,000 undefined
20134.15 M undefined-2.61 M undefined-2.86 M undefined
20125.68 M undefined-1.45 M undefined-1.58 M undefined
20115.58 M undefined20,000 undefined-160,000 undefined
20104.83 M undefined920,000 undefined720,000 undefined

Cambridge Cognition Holdings Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
201020112012201320142015201620172018201920202021202220232024e2025e2026e
45545566656101213141618
-25.00--20.0025.00-20.00---16.6720.0066.6720.008.337.6914.2912.50
100.0080.0080.0075.0080.0080.0083.33100.0083.3360.0083.3380.0075.0076.92---
444344565358910000
00-1-20000-1-3000-1013
---20.00-50.00-----16.67-60.00----7.69-6.2516.67
00-1-20000-1-2000-3013
---100.00-----100.00------200.00
5.234.945.9813.4216.4416.8319.4720.420.5523.4129.7831.5331.1834.6000
-----------------
Details

Keystats

ⓘ

Revenue and Growth

The Cambridge Cognition Holdings Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Cambridge Cognition Holdings is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Cambridge Cognition Holdings provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Cambridge Cognition Holdings's financial health and stability.

Assets

Cambridge Cognition Holdings's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Cambridge Cognition Holdings must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Cambridge Cognition Holdings after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Cambridge Cognition Holdings's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2010201120122013201420152016201720182019202020212022
00-1-20000-1-3000
0000000000000
0000000000000
0000000000132
0000000000000
0000000000000
0000000000000
000-200000-2131
0000000000000
0000000000000
0000000000000
0000000000000
0000000000000
0004001002100
0004001002100
-------------
0000000000000
0001001000231
0.520.49-0.75-2.49-0.74-0.840.43-0.67-0.67-2.380.973.891.48
0000000000000

Cambridge Cognition Holdings stock margins

The Cambridge Cognition Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cambridge Cognition Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cambridge Cognition Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Cambridge Cognition Holdings's sales revenue. A higher gross margin percentage indicates that the Cambridge Cognition Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Cambridge Cognition Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Cambridge Cognition Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Cambridge Cognition Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Cambridge Cognition Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Cambridge Cognition Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Cambridge Cognition Holdings Margin History

Cambridge Cognition Holdings Gross marginCambridge Cognition Holdings Profit marginCambridge Cognition Holdings EBIT marginCambridge Cognition Holdings Profit margin
2026e79.9 %21.44 %17.18 %
2025e79.9 %10.58 %11.47 %
2024e79.9 %5.11 %0 %
202379.9 %-13.68 %-25.96 %
202273.91 %-1.09 %-3.24 %
202180.04 %2.62 %4.46 %
202080.36 %-9.55 %-6.5 %
201977.21 %-61.84 %-57.54 %
201885.33 %-24.26 %-23.51 %
201790.76 %-4.22 %-3.82 %
201685.66 %1.69 %3.96 %
201588.3 %-13.07 %-15.51 %
201485.07 %-5.24 %-2.98 %
201388.19 %-62.89 %-68.92 %
201278.7 %-25.53 %-27.82 %
201183.51 %0.36 %-2.87 %
201083.23 %19.05 %14.91 %

Cambridge Cognition Holdings Stock Sales Revenue, EBIT, Earnings per Share

The Cambridge Cognition Holdings earnings per share therefore indicates how much revenue Cambridge Cognition Holdings has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Cambridge Cognition Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Cambridge Cognition Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Cambridge Cognition Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cambridge Cognition Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Cambridge Cognition Holdings Revenue, EBIT and net profit per share

DateCambridge Cognition Holdings Sales per ShareCambridge Cognition Holdings EBIT per shareCambridge Cognition Holdings Earnings per Share
2026e0.51 undefined0 undefined0.09 undefined
2025e0.46 undefined0 undefined0.05 undefined
2024e0.41 undefined0 undefined0 undefined
20230.39 undefined-0.05 undefined-0.1 undefined
20220.4 undefined-0 undefined-0.01 undefined
20210.32 undefined0.01 undefined0.01 undefined
20200.23 undefined-0.02 undefined-0.01 undefined
20190.22 undefined-0.13 undefined-0.12 undefined
20180.3 undefined-0.07 undefined-0.07 undefined
20170.33 undefined-0.01 undefined-0.01 undefined
20160.35 undefined0.01 undefined0.01 undefined
20150.3 undefined-0.04 undefined-0.05 undefined
20140.35 undefined-0.02 undefined-0.01 undefined
20130.31 undefined-0.19 undefined-0.21 undefined
20120.95 undefined-0.24 undefined-0.26 undefined
20111.13 undefined0 undefined-0.03 undefined
20100.92 undefined0.18 undefined0.14 undefined

Cambridge Cognition Holdings business model

Cambridge Cognition Holdings PLC is a British company specializing in the development of computer programs for cognitive assessment of patients in medical research and development. The company was founded in 1986 by a group of neuroscientists from the University of Cambridge, who aimed to conduct neuropsychological research in standardized and automated form. The development of tests that could be conducted on computers was intended to increase the accuracy and efficiency of neuropsychological assessment of patients. The business quickly grew into a successful company, and Cambridge Cognition Holdings PLC was listed on the London Stock Exchange in 2013. The core business of the company is to provide tests and tools for assessing the cognitive functions of patients in medical research and development. Cambridge Cognition's products and services can be divided into two main categories: cognitive tests and digital therapeutic interventions. Cambridge Cognition's cognitive tests include a variety of specialized tests designed to assess the cognitive functions of patients. These tests cover areas such as memory, attention, executive function, and fine motor skills. The tests can be conducted on desktop computers, tablets, or mobile devices, offering standardization, efficiency, and reproducibility in the assessment of patients' cognitive functions. Another branch of the company is the development of digital therapeutic interventions. These interventions are designed to improve or maintain the cognitive functions of patients by triggering specific brain activities. An example of this is the "CogniFit" program for improving the cognitive abilities of older people. By using computer-based tests, the program aims to enhance users' cognitive functions and help slow down cognitive decline in old age. Cambridge Cognition Holdings PLC is not only involved in medical research but also in the pharmaceutical industry. The company offers services to pharmaceutical companies for conducting clinical studies testing the effectiveness of new drugs on cognitive functions. The combination of Cambridge Cognition's cognitive tests with clinical research provides an accurate assessment of the impact of medications on patients' cognitive functions. Cambridge Cognition's business model is based on the development and marketing of cognitive tests and digital therapeutic interventions. The company collaborates with medical research and development departments of pharmaceutical companies, academic institutions, and clinics. It also provides services related to clinical research to evaluate the effectiveness of new drugs on cognitive functions. Overall, Cambridge Cognition Holdings PLC is a leading company in medical research and development. Through the development of cognitive tests and digital therapeutic interventions, the company can contribute to improving patients' cognitive functions and accelerate the development of new medical therapies. Cambridge Cognition Holdings is one of the most popular companies on Eulerpool.com.

Cambridge Cognition Holdings SWOT Analysis

Strengths

Cambridge Cognition Holdings PLC has established a strong reputation in the field of cognitive assessment and digital health solutions. The company's expertise in developing innovative technology and software for cognitive testing sets it apart from competitors. Its products are widely recognized and trusted by healthcare professionals and researchers.

The company has a diverse customer base, both in terms of geographies and sectors. This broad market presence provides Cambridge Cognition Holdings PLC with stability and opportunities for growth. Furthermore, the company's partnerships with renowned academic institutions and pharmaceutical companies enhance its credibility and open doors to collaborative research and development.

Weaknesses

One of the weaknesses of Cambridge Cognition Holdings PLC is its dependency on key clients and contracts. If the company loses a significant client or fails to renew a major contract, it may experience a decline in revenue. Additionally, the company may face challenges in effectively scaling its operations to meet increasing demand for its solutions.

Cambridge Cognition Holdings PLC operates in a rapidly evolving market, which means that it needs to continuously invest in research and development to stay ahead. This constant need for innovation creates a financial burden and poses a risk if the company fails to keep pace with technological advancements.

Opportunities

An opportunity for Cambridge Cognition Holdings PLC lies in the growing demand for digital health solutions and cognitive assessment tools. The global healthcare industry is increasingly recognizing the importance of early detection and management of cognitive disorders, creating a favorable market environment for the company's products.

Expansion into new geographical markets can also be a significant opportunity for the company. By targeting regions with underutilized cognitive assessment technologies, Cambridge Cognition Holdings PLC can tap into untapped markets and increase its customer base.

Threats

One of the threats faced by Cambridge Cognition Holdings PLC is the presence of strong competitors in the market. Other companies offering cognitive assessment solutions and digital health platforms may have similar or even superior offerings, which can impact the company's market share and profitability.

Moreover, regulatory challenges and changes in healthcare policies can pose a threat to the operations of Cambridge Cognition Holdings PLC. Compliance with evolving regulations and maintaining high data security standards is crucial for the company's success and reputation.

Cambridge Cognition Holdings historical P/E ratio, EBIT, and P/S ratio.

Cambridge Cognition Holdings shares outstanding

The number of shares was Cambridge Cognition Holdings in 2023 — This indicates how many shares 34.597 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Cambridge Cognition Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Cambridge Cognition Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Cambridge Cognition Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cambridge Cognition Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Cambridge Cognition Holdings.

Cambridge Cognition Holdings latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20210 0  (-3.23 %)2021 Q2
1

Cambridge Cognition Holdings list of shareholders

%
Name
Stocks
Change
Date
9.97 % Canaccord Genuity Wealth Management3,529,5001,469,5009/5/2023
8.05 % Lombard Odier Asset Management (Europe) Ltd2,849,72105/11/2023
7.02 % Gordon (Brett)2,485,000285,0002/19/2024
4.95 % J O Hambro Capital Management Limited1,750,00005/11/2023
4.04 % Octopus Investments Limited1,429,77105/11/2023
3.20 % LGT Capital Partners Ltd.1,131,87005/11/2023
2.97 % AXA Investment Managers UK Ltd.1,050,00005/11/2023
2.94 % AXA Investment Managers Paris1,040,000012/31/2022
14.21 % Wray (Nigel William)5,026,54705/11/2023
1.97 % 2312 North, LLC698,40301/15/2024
1
2
3
4
...
5

Cambridge Cognition Holdings Executives and Management Board

Dr. Matthew Stork
Cambridge Cognition Holdings Chief Executive Officer, Executive Director (since 2019)
Compensation 342,000
Mr. Stephen Symonds48
Cambridge Cognition Holdings Chief Financial Officer, Executive Director (since 2022)
Compensation 176,000
Dr. Steven Powell
Cambridge Cognition Holdings Non-Executive Chairman of the Board (since 2015)
Compensation 45,000
Mr. Richard Bungay54
Cambridge Cognition Holdings Non-Executive Independent Director
Compensation 30,000
Ms. Debra Leeves
Cambridge Cognition Holdings Non-Executive Independent Director
Compensation 30,000
1
2

Most common questions regarding Cambridge Cognition Holdings

What values and corporate philosophy does Cambridge Cognition Holdings represent?

Cambridge Cognition Holdings PLC represents a commitment to scientific excellence and innovation in cognitive research. With a focus on developing cutting-edge technology and software solutions, the company aims to transform the understanding and treatment of brain-related disorders. Cambridge Cognition places great emphasis on collaboration and partnerships with renowned academic institutions and pharmaceutical companies, allowing the company to remain at the forefront of cognitive science. With a dedication to improving patient outcomes, Cambridge Cognition strives to provide accurate and reliable assessments for clinical trials and patient care. By continuously pushing the boundaries of cognitive assessment, this company is leading the way in advancing neuroscience research.

In which countries and regions is Cambridge Cognition Holdings primarily present?

Cambridge Cognition Holdings PLC is primarily present in the United Kingdom.

What significant milestones has the company Cambridge Cognition Holdings achieved?

Cambridge Cognition Holdings PLC, a leading cognitive neuroscience company, has achieved significant milestones in its journey. The company has successfully developed and launched innovative digital health technologies and cognitive assessment solutions. It has collaborated with renowned research institutions and pharmaceutical companies, forging strong partnerships to advance scientific knowledge and drive clinical research. Cambridge Cognition Holdings PLC has also expanded its global reach, effectively penetrating new markets and establishing a solid presence across the globe. Through continuous innovation and dedication, the company has positioned itself as a trusted leader in the field, empowering researchers and clinicians to make informed decisions for better patient outcomes.

What is the history and background of the company Cambridge Cognition Holdings?

Cambridge Cognition Holdings PLC, a leading neuroscience technology company, has a rich history and background. Founded in 1999, the company focuses on developing cutting-edge digital health solutions. It began as a spin-out from the University of Cambridge, leveraging the world-class research and expertise of the university. Cambridge Cognition Holdings PLC has since established itself as a global leader in cognitive assessment and monitoring. Its innovative software tools and digital health technologies, backed by extensive research, enable the assessment of cognitive health and the early detection of neurological disorders. With a strong emphasis on scientific rigor and rigorous standards, Cambridge Cognition Holdings PLC continues to revolutionize cognitive healthcare.

Who are the main competitors of Cambridge Cognition Holdings in the market?

Cambridge Cognition Holdings PLC faces competition from several key players in the market. Some of its main competitors include Cogstate Ltd, which offers cognitive assessment tools and services; ProPhase Labs Inc, known for their innovative cognitive health products; and Brain Resource Company Pty Ltd, a company that specializes in online brain health assessments and training. These competitors strive to offer similar services and solutions, creating a competitive landscape for Cambridge Cognition Holdings PLC.

In which industries is Cambridge Cognition Holdings primarily active?

Cambridge Cognition Holdings PLC is primarily active in the healthcare and pharmaceutical industries.

What is the business model of Cambridge Cognition Holdings?

The business model of Cambridge Cognition Holdings PLC is focused on providing digital solutions in cognitive health, clinical trials, and neuroscience research. The company offers software tools and services that enable the assessment of cognitive function and mental health. Cambridge Cognition's technology is used by pharmaceutical companies, research institutions, and healthcare providers to improve the understanding and treatment of neurological and psychiatric disorders. With their innovative solutions and expertise in cognition, the company aims to help customers in accelerating drug development, advancing scientific research, and ultimately improving patient outcomes. Cambridge Cognition Holdings PLC is committed to delivering cutting-edge solutions in the field of cognitive health.

What is the P/E ratio of Cambridge Cognition Holdings 2024?

The Cambridge Cognition Holdings P/E ratio is 0.

What is the P/S ratio of Cambridge Cognition Holdings 2024?

The Cambridge Cognition Holdings P/S ratio is 1.03.

What is the AlleAktien quality score of Cambridge Cognition Holdings?

The AlleAktien quality score for Cambridge Cognition Holdings is 4/10.

What is the revenue of Cambridge Cognition Holdings 2024?

The expected Cambridge Cognition Holdings revenue is 14.42 M GBP.

How high is the profit of Cambridge Cognition Holdings 2024?

The profit cannot currently be calculated for Cambridge Cognition Holdings.

What is the business model of Cambridge Cognition Holdings

Cambridge Cognition Holdings PLC is a leading company in the field of digital cognitive health research. The company's business model is based on the development and provision of software products to support clinical studies and research projects in the field of cognitive health. The company offers various digital tools that help measure and improve patients' cognitive health. The focus is on researching diseases such as Alzheimer's, schizophrenia, depression, and anxiety disorders. The tools include mobile applications, web applications, and software solutions that can run on tablets and other digital devices. Cambridge Cognition Holdings PLC distributes its tools and services to research institutes as well as companies in the pharmaceutical and biotech industries. The company works closely with its customers to develop and offer customized solutions. The latest scientific knowledge is used, and the needs and requirements of customers are taken into account when developing new products. Another important aspect of Cambridge Cognition Holdings PLC's business model is the acquisition of research projects. The company uses its own products and expertise to conduct clinical studies in the field of cognitive health. The data from these studies can then be used by the company's customers to develop new drugs and therapies. A central aspect of Cambridge Cognition Holdings PLC's business model is innovation. The company is constantly striving to further develop its products and services and offer new solutions in the field of digital cognitive health research. To this end, the company continuously invests in research and development and works closely with leading scientists in this field. Cambridge Cognition Holdings PLC aims to play a leading role in digital cognitive health research. The company relies on open and transparent collaboration with its customers and partners. By pooling resources and expertise, innovative solutions in the field of cognitive health are to be developed, which provide real added value for patients and society as a whole. Overall, Cambridge Cognition Holdings PLC's business model is focused on continuous growth and success. By developing and improving tools and services in the field of digital cognitive health research, the company aims to accelerate research and improve disease treatment.

What is the Cambridge Cognition Holdings dividend?

Cambridge Cognition Holdings pays a dividend of 0 GBP distributed over payouts per year.

How often does Cambridge Cognition Holdings pay dividends?

The dividend cannot currently be calculated for Cambridge Cognition Holdings or the company does not pay out a dividend.

What is the Cambridge Cognition Holdings ISIN?

The ISIN of Cambridge Cognition Holdings is GB00B8DV9647.

What is the Cambridge Cognition Holdings WKN?

The WKN of Cambridge Cognition Holdings is A1T9LW.

What is the Cambridge Cognition Holdings ticker?

The ticker of Cambridge Cognition Holdings is COG.L.

How much dividend does Cambridge Cognition Holdings pay?

Over the past 12 months, Cambridge Cognition Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cambridge Cognition Holdings is expected to pay a dividend of 0 GBP.

What is the dividend yield of Cambridge Cognition Holdings?

The current dividend yield of Cambridge Cognition Holdings is .

When does Cambridge Cognition Holdings pay dividends?

Cambridge Cognition Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cambridge Cognition Holdings?

Cambridge Cognition Holdings paid dividends every year for the past 0 years.

What is the dividend of Cambridge Cognition Holdings?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cambridge Cognition Holdings located?

Cambridge Cognition Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cambridge Cognition Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cambridge Cognition Holdings from 7/18/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 7/18/2024.

When did Cambridge Cognition Holdings pay the last dividend?

The last dividend was paid out on 7/18/2024.

What was the dividend of Cambridge Cognition Holdings in the year 2023?

In the year 2023, Cambridge Cognition Holdings distributed 0 GBP as dividends.

In which currency does Cambridge Cognition Holdings pay out the dividend?

The dividends of Cambridge Cognition Holdings are distributed in GBP.

All fundamentals about Cambridge Cognition Holdings

Our stock analysis for Cambridge Cognition Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cambridge Cognition Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.